1[1]Sato GD, Kawamoto T, Le AD, et al. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors [J ]. Mol Biol Med, 1983,1:511～ 529.
2[2]Grandis JR,Mdham MF,Goodling WE, etal. LevelsofTGF-αand EGFR protein in head and neck squamous cell carcinoma and patient survival[J ]. J Natl Cancer Inst , 1998,90 ( 11 ): 824～ 823.
3[3]Albanell J. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor /transforming growth factor-[ alpha] expression in head and neck squarmous carcinoma and inhibition by anti-epidermal growth factor receptor treatments[ J ]. Cancer Res, 2001, 61, 6500～ 6510.
4[4]Nicholson RI,Gee J M, Harper ME, et al. EGFR and cancer prognosis[J ]. Eur J of Cancer 2001,37 (Suppl 4) :s 9～15.
5[5]Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy[J ]. Oncogene, 2000,19: 6550～ 6565.
6[6]Ryan PD, Chabner BA. On receptor inhibitors and chemotherapy[J]. Clin Cancer Res,2000,6(12) :4607～4609.
7[7]Hanahan D, Weinberg RA. The hallmarks of cancer[J ]. Cell ,2000,100:57～70.
8[8]Albanel J, Codony-Servat J, Rojo F, et al. Activiated extracellu lar signal-regulated kina~s: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti -EGF receptor treatment [J ]. Cancer Res, 2001,61:6500～6510.
9[9]Kopp R, Rothbauer E, Ruge M, et al. Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinonas: evidence for new therapeutic options [J ]. Recent Results Cancer Res, 2003,162:115 ～ 132.
10[10]Huang SM, Li J, Armstrong EA, et al. Modulation of radiation rcsponse and tumor-induced angiogenesis following EGFR in hibition by ZD1839 (Iressa)[J]. Cancer Res , 2002,62: 4300～4306.
